CIK 0001513525 · Non-accelerated filer<br>Smaller reporting company
Azora Therapeutics, Inc. (DE)
Sign in to watch- Ticker
- AZR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 800667150
- Phone
- 434-422-9800
- Business address
- 16501 VENTURA BLVD, SUITE 400, ENCINO, CA, 91436
- Former names
- ADIAL PHARMACEUTICALS, INC., Adial Pharmaceuticals, L.L.C., ADial Pharmaceuticals, L.L.C.
- D Other Notice of Sales of Unregistered Securities
- 4 Derivatives Options or other derivatives
- 8-K Event Material agreement · Unregistered share sale
- 4 Grant or award Chief Financial Officer acquired 157,500 shares (grant or award)
- 4 Grant or award Director acquired 240,800 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Executive Officer acquired 420,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 8-K Event Delisting notice
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Regulation FD disclosure
- 8-K Event Shareholder vote results
- 8-K Event Results of operations
- 10-K Report Annual Report
- DEFA14A Proxy Proxy Materials
- 8-K Event Material agreement · Regulation FD disclosure
Page 12 of 30 · 581 filings